Actinium Pharmaceuticals Inc.

Oct 24, 2018

Actinium Pharmaceuticals Announces Participation at BIO-Europe® 24th Annual International Partnering Conference

Oct 22, 2018

Actinium Pharmaceuticals Announces Webinar Showcasing Actimab-A Post Phase 2 Trial Plans and Actimab-MDS Regulatory Update

Oct 01, 2018

Actinium Launches Iomab-ACT Program Offering Its Targeted, Chemo-Free, Lymphodepletion Technology as a Universal Solution to CAR-T Product Developers

Sep 26, 2018

Actinium Pharmaceuticals to Host Webinar Today Introducing Next Generation Targeted Lymphodepletion Technology for CAR-T

Sep 20, 2018

Actinium Pharmaceuticals to Participate in the Oppenheimer & Co. Fall Summit Focused on Specialty Pharma and Rare Disease

Sep 06, 2018

Actinium Appoints Robert N. Daly, Ph.D. to Newly Created Role of Vice President, Head of Clinical Operations

Sep 04, 2018

Actinium Pharmaceuticals to Present at Upcoming Investor Conferences and Participate in Featured Panel Discussions

Aug 14, 2018

Actinium to Provide Update on Pivotal Phase 3 SIERRA Trial Following Positive Data Monitoring Committee Meeting

Aug 30, 2017

Daily Technical Summary Reports on Biotech Stocks -- Actinium Pharma, BioPharmX, Matinas BioPharma, and 22nd Century

Jul 25, 2017

Stock Performance Review on Biotech Industry -- BioPharmX, AmpliPhi Biosciences, Actinium Pharma, and Matinas BioPharma